Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials-Reference-Cited by-同舟云学术

Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials

Author:

Astorino Stefano¹²,Astorre Paolo³,Pasquini Paola⁴,Di Nunno Donato¹²,Pellegrini Federico³,Paolino Giovanni⁵⁶^ORCID

Affiliation:

1. Dermatology and Venereology; Celio Military Hospital; Rome Italy

2. Department of Internal Medicine; Celio Military Hospital; Rome Italy

3. Department of Oncology; Celio Military Hospital; Rome Italy

4. Service of Surgical Pathology; Celio Military Hospital; Rome Italy

5. Unit of Dermatology; IRCCS University Vita-Salute San Raffaele; Milan Italy

6. Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche; La Sapienza University of Rome; Rome Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

Reference7 articles.

1. Imiquimod: a novel treatment for lentigo maligna;Ahmed;The British Journal of Dermatology,2000

3. Lentigo maligna: Diagnosis and treatment;De Luca;Giornale Italiano di Dermatologia e Venereologia,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Lentigo Maligna;European Handbook of Dermatological Treatments;2023